Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment.
Journal Information
Full Title: Acta Pharmacol Sin
Abbreviation: Acta Pharmacol Sin
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests The authors declare no competing interests."
Funding Disclosure
Evidence found in paper:
"This work was supported by funding from National Institutes of Health (U54CA198999 and R01 CA178748), Department of Defense Congressionally Directed Medical Research Programs-Peer Reviewed Cancer Research Program Idea Award (CA150391), and The University of North Carolina Research Opportunity Initiative grant."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025